Ads
related to: when was docetaxel fda approved
Search results
Results From The WOW.Com Content Network
Docetaxel is in the taxane family of medications. [9] It works by disrupting the normal function of microtubules and thereby stopping cell division. [6] Docetaxel was patented in 1986 and approved for medical use in 1995. [10] It is on the World Health Organization's List of Essential Medicines. [11] Docetaxel is available as a generic ...
In December 2014, the FDA approved ramucirumab in combination with docetaxel for treatment of metastatic non-small-cell lung carcinoma (NSCLC) with disease progression during or after first-line platinum-containing chemotherapy. The approval was based on REVEL trial. [12]
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
On Monday, Johnson & Johnson subsidiary Janssen Research & Development confirmed that the FDA has approved its oral, once-daily medication Zytiga for treatment of metastatic castration-resistant ...
On Tuesday, the FDA approved NovoCure’s (NASDAQ:NVCR) Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for adult patients with metastatic non-small cell lung cancer (mNSCLC ...
The market for prostate cancer treatment has become hyper competitive as drug companies vie for their share of $3 billion in annual sales formerly captured by Sanofi's Taxotere before losing ...
Paclitaxel (Taxol) and docetaxel (Taxotere) are widely used as chemotherapy agents. [ 2 ] [ 3 ] Cabazitaxel was FDA approved to treat hormone-refractory prostate cancer . Taxanes present difficulties in formulation as medicines because they are poorly soluble in water.
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: when was docetaxel fda approved